Read the latest.
Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof Protection from the Greatest Viral Threats
Endpoints News: Flagship unwraps new AI biotech that looks to predict variants before they’re here
Boston Business Journal: Flagship-backed startup aims to 'close off the escape routes' for evolving viruses
Bloomberg: Startup Taps Artificial Intelligence to Predict Covid Variants
BioPharma Dive: Moderna founder launches Apriori with $50M to stay ahead of virus variants